Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abediterol Single Dose PK/PD in Asthma
NCT02777827Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of abediterol in asthma (6 arms), sponsored by AstraZeneca. Primary endpoint: Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1). Started Jun 2016; status: completed.
02
Drugs
abediterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02777827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777827.